Download Mobile App

Video Library

Novel Intraoperative Probe Developed for Cancer Surgery

By MedImaging International staff writers
Posted on 03 Jul 2017

Image: A depiction of the new multimodal probe in use during surgery, together with a Magnetic Resonance Imaging (MRI) scan of a brain cancer patient, showing the tumor in red (Photo courtesy of Frédéric Leblond and Kevin Petrecca).

An innovative intraoperative probe for detecting different types of tumor cells has been developed by researchers in Canada.

The multimodal hand-held Raman optical spectroscopy probe enables surgeons to detect nearly all cancer cells during brain surgery.

The scientists from the Polytechnique Montréal (Montréal, Canada), and two other hospitals and Universities developed the hand-held Raman spectroscopy probe. The device is now accurate, sensitive and specific enough for detecting brain, colon, lung, and skin cancer cells. During intraoperative testing the probe showed nearly 100% sensitivity for detecting cancer cells. Details of the breakthrough technology were published in the June 28, 2017, issue of the American Association for Cancer Research journal Cancer Research.

The unique feature of the new second-generation system is that it can be used in real-time, during a surgical procedure, to detect cancer cells. The multimodal probe uses intrinsic fluorescence spectroscopy, and diffuse-reflectance spectroscopy technologies. A randomized clinical trial is currently under way using the first-generation Raman spectroscopy probe for patients with gliomas, and will help researchers develop a protocol for a clinical trial of the new second-generation multimodal probe.

Chief of Neurosurgery, brain cancer researcher Dr. Petrecca, said, "Minimizing, or completely eliminating, the number of cancer cells during surgery is a critical part of cancer treatment, yet detecting cancer cells during surgery is challenging. Often it is impossible to visually distinguish cancer from normal brain, so invasive brain cancer cells frequently remain after surgery, leading to cancer recurrence and a worse prognosis. Surgically minimizing the number of cancer cells improves patient outcomes. A technology with extremely high accuracy is necessary, since surgeons will be using this information to help determine if tissues contain cancer cells or not."

Related Links:
Polytechnique Montréal

Visit expo >

X-ray Diagnostic System

FDX Visionary-A

Half Apron

Demi

High-Precision QA Tool

DEXA Phantom

Computed Tomography System

Aquilion ONE / INSIGHT Edition

Latest General/Advanced Imaging News

Channels

Radiography

view channel

Image: Screening mammograms and artificial intelligence (AI) score changes over time in two individuals with screen-detected cancer. Full-field digital mammograms show craniocaudal (top) and mediolateral (bottom) views of the left and right breast (Photo courtesy of Radiological Society of North America)

AI Mammography Tools Detect Early Breast Cancer Signs Years Before Diagnosis

Breast cancer screening aims to detect tumors before symptoms develop, but subtle mammographic changes can appear years before diagnosis and may be missed during routine reads. Delayed detection can lead... Read more

$Image: Kyushu University researchers use Dynamic Chest Radiography (DCR) to evaluate the severity of Pulmonary Regurgitation (PR), a common complication after treatment of the congenital heart disease Tetralogy of Fallot. The analysis only requires the patient to hold their breath for seven seconds for a sequence of images of their heart to be taken. The images are then analyzed and extracted into a waveform that can show the severity of PR. The new technique\\\'s detection accuracy of severe PR is 93%, with a sensitivity of 93% and a specificity of 94%. (Photo courtesty of Kyushu University/Yuzo Yamasaki)$

Rapid X-Ray Test Quantifies Pulmonary Regurgitation After Tetralogy of Fallot Repair

Tetralogy of Fallot is the most common cyanotic congenital heart defect and can leave patients with pulmonary valve regurgitation, a backward flow of blood into the right ventricle after repair.... Read more

Image credit: Shu-Han Chen / St. Paul’s Hospital / National Taiwan University

AI Tool Flags Osteoporosis Risk from Routine Chest X-Rays

Osteoporosis is a progressive loss of bone density that is often silent until a fracture occurs. Current screening frameworks concentrate on older women and select high-risk groups. Many men, younger adults,... Read more

Simple Chest X-Ray Measure Predicts Survival After Lung Cancer Surgery

Obstructive ventilatory disorder, marked by airflow limitation that reduces breathing efficiency, increases postoperative risk in patients with lung cancer. Although surgery offers the best chance of cure,... Read more

MRI

view channel

International Study Assesses AI for Prostate Cancer MRI Interpretation

Prostate cancer is a leading cause of cancer morbidity in men, and accurate early diagnosis hinges on expert interpretation of prostate magnetic resonance imaging (MRI). Rapid adoption of MRI-first pathways... Read more

$Image: By training the AI with simulations, researchers can reconstruct brain images with high precision using only one-tenth of the data typically required in magnetic resonance imaging. The image shows a metric known as “fractional anisotropy”—an index of myelination—obtained using conventional methods and with the new approach (Photo courtesy of Instituto de Neurociencias UMH CSIC)$